SCHEMBL8786543

SCHEMBL8786543

O=c1cc(-c2ccccc2)oc2ccc(OCCCCCCCCBr)cc12

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 17/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8786565 0.89 SIGMAR1 (0.80) SIGMAR1
SCHEMBL8786926 0.88 SIGMAR1 (0.78) SIGMAR1
SCHEMBL8786494 0.87 SIGMAR1 (0.77) SIGMAR1
SCHEMBL28647889 0.86 SIGMAR1 (0.78) SIGMAR1
SCHEMBL8787231 0.85 SIGMAR1 (1.00) SIGMAR1
SCHEMBL8787025 0.85 SIGMAR1 (1.00) SIGMAR1
SCHEMBL8786990 0.85 SIGMAR1 (1.00) SIGMAR1
SCHEMBL8788283 0.85 SIGMAR1 (1.00) SIGMAR1
SCHEMBL8786706 0.85 SIGMAR1 (1.00) SIGMAR1
SCHEMBL8786635 0.85 SIGMAR1 (1.00) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0533804-B1 SIGMA BINDING SITE AGENTS GUILFORD PHARM INC (US) 1997-12-17 — — EP disclosed
US-5359098-A For psychological disorders; antipsychotic drugs GUILFORD PHARMACEUTICALS INC. (US) 1994-10-25 — — US disclosed
US-5278174-A Receptivity SCIOS NOVA, INC. (US) 1994-01-11 — — US disclosed
EP-0533804-A4 SIGMA BINDING SITE AGENTS — 1993-04-21 — — EP disclosed
EP-0533804-A1 SIGMA BINDING SITE AGENTS GUILFORD PHARMACEUTICALS INC. (US) 1993-03-31 — — EP disclosed
WO-1991018597-A1 SIGMA BINDING SITE AGENTS ERICKSON RONALD H (US) 1991-12-12 — — WO disclosed
Send feedback